Analyzing the Future of Adeno-Associated Viral Vectors Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the adeno-associated viral vectors market size evolved in recent years?
The adeno-associated viral vectors market is forecast to grow from $2.69 billion in 2024 to $3.17 billion in 2025, at a CAGR of 17.9%. Growth is fueled by vaccine development, increased funding, academic and industrial collaborations, the expansion of clinical trials, and heightened public awareness and advocacy.
What are the predictions for the adeno-associated viral vectors market size in the coming years?
The adeno-associated viral vectors market is projected to grow to $6.08 billion by 2029, at a CAGR of 17.6%. Growth is driven by expanding therapeutic applications, the rise in genetic and neurological disorders, regulatory approvals, and cost reductions in production. Major trends include advancements in gene therapy, scalable manufacturing, and investments in technological innovations.
Get your adeno-associated viral vectors market report here!
What key factors are fueling the growth of the adeno-associated viral vectors market?
The increasing prevalence of genetic disorders is expected to drive the adeno-associated viral vectors market. Genetic disorders, caused by abnormalities in DNA, are becoming more common due to better diagnostics and higher reproductive age. Adeno-associated viral vectors are used in gene therapy to treat genetic disorders by delivering corrective genes to targeted cells. For example, the World Health Organization estimated that 240,000 infant deaths each year are caused by congenital diseases. This rise in genetic disorders is expected to drive the demand for adeno-associated viral vectors.
How is the global adeno-associated viral vectors market divided into key segments?
The adeno-associated viral vectors market covered in this report is segmented –
1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies
2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo
3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By Application Area: Gene Therapy, Cell Therapy, Vaccines
Subsegments:
1) By Gene Augmentation: Inherited Genetic Disorders, Muscular Dystrophy, Cystic Fibrosis, Hemophilia
2) By Immunotherapy: Cancer Immunotherapy, Viral Infections Immunotherapy, Autoimmune Diseases Immunotherapy
3) By Other Types Of Therapies: Gene Editing, RNA Therapy, Antiviral Therapy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15969&type=smp
Who are the key firms paving the way for growth in the adeno-associated viral vectors market?
Major companies operating in the adeno-associated viral vectors market are Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics
Which trends are expected to transform the adeno-associated viral vectors market?
Companies in the adeno-associated viral vectors market are offering off-the-shelf replication-capsid plasmids to streamline gene therapy production. These plasmids are essential in the creation of AAV vectors for gene therapies. For example, in January 2024, Charles River Laboratories launched a new line of off-the-shelf replication-capsid plasmids that simplify AAV-based gene therapy processes. These ready-to-use plasmids cut manufacturing efforts and adhere to regulatory guidelines, ensuring smooth IND and CTA submissions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15969
What regions are contributing significantly to the growth of the adeno-associated viral vectors market?
North America was the largest region in the adeno-associated viral vectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated viral vectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
The Antiviral & Antimicrobial Coatings Global Market Report 2024
Antiviral Combination Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiviral-combination-therapy-global-market-report
Viral Vectors And Plasmid DNA Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
